Bjørn Bendz
- Head of CCU; MD, PhD
- +47 23 07 06 44
Publications 2022
A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy
Clin. Transplant., 36 (1), e14488
DOI 10.1111/ctr.14488
Publications 2021
Outcome in refractory out-of-hospital cardiac arrest before and after implementation of an ECPR protocol
Resuscitation, 162, 35-42
DOI 10.1016/j.resuscitation.2021.01.038
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
J. Am. Coll. Cardiol., 77 (15), 1845-1855
DOI 10.1016/j.jacc.2021.02.049
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
Mediat. Inflamm., 2021, 5525917
DOI 10.1155/2021/5525917
Prognostic impact of non-improvement of global longitudinal strain in patients with revascularized acute myocardial infarction
Int. J. Cardiovasc. Imaging, 37 (12), 3477-3487
DOI 10.1007/s10554-021-02349-2
Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT)
PLoS One, 16 (3), e0247358
DOI 10.1371/journal.pone.0247358
Publications 2020
Acute coronary syndromes in older patients: does older age matter?
Lancet, 396 (10251), 585-587
Periprocedural myocardial injury in the EXCEL trial DISCUSSION
Eur. Heart J., 41 (17), 1703
DOI 10.1093/eurheartj/ehaa182
Operative survival in patients with acute aortic disease in the era of newer oral anticoagulants
Open Heart, 7 (2), e001278
DOI 10.1136/openhrt-2020-001278
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
Atherosclerosis, 296, 74-82
DOI 10.1016/j.atherosclerosis.2019.12.008
Rethinking rehabilitation after percutaneous coronary intervention: a protocol of a multicentre cohort study on continuity of care, health literacy, adherence and costs at all care levels (the CONCARD(PCI))
BMJ Open, 10 (2), e031995
DOI 10.1136/bmjopen-2019-031995
The impact of semi-automatic versus manually adjusted assessment of global longitudinal strain in post-myocardial infarction patients
Int. J. Cardiovasc. Imaging, 36 (7), 1283-1290
DOI 10.1007/s10554-020-01826-4
Patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris randomised to an invasive versus conservative strategy: angiographic and procedural results from the After Eighty study
Open Heart, 7 (2), e001256
DOI 10.1136/openhrt-2020-001256
Publications 2019
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Open Heart, 6 (2), UNSP e001108
DOI 10.1136/openhrt-2019-001108
Intra-aortic balloon pump in acute chest pain and cardiogenic shock - a long-term follow-up
Scand. Cardiovasc. J., 53 (6), 337-341
DOI 10.1080/14017431.2019.1657938
Mechanical dispersion as amarker of left ventricular dysfunction and prognosis in stable coronary artery disease
Int. J. Cardiovasc. Imaging, 35 (7), 1265-1275
DOI 10.1007/s10554-019-01583-z
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
Am. Heart J., 208, 37-46
DOI 10.1016/j.ahj.2018.10.005
Publications 2018
Kateterbasert behandling av aortastenose - skrøpelighetsvurdering av pasienter.
Hjerteforum, 31 (3), 49-54
PublikaID 440
Intra-Aortic Balloon Pump Optimizes Myocardial Function During Cardiogenic Shock
JACC-Cardiovasc. Imag., 11 (3), 512-514
DOI 10.1016/j.jcmg.2017.05.019
Reduced inflammatory response by transcatheter, as compared to surgical aortic valve replacement
Scand. Cardiovasc. J., 52 (1), 43-50
DOI 10.1080/14017431.2017.1416157
Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1 beta in non-ST-elevation myocardial infarction
Int. J. Cardiol., 271, 1-7
DOI 10.1016/j.ijcard.2018.04.136
IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
Front. Immunol., 9, 2035
DOI 10.3389/fimmu.2018.02035
Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective
Int. J. Nurs. Stud., 88, 16-24
DOI 10.1016/j.ijnurstu.2018.07.013
In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are beta-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot Study
Cardiology, 140 (3), 152-154
DOI 10.1159/000490656
Health-related quality of life in older patients with acute coronary syndrome randomised to an invasive or conservative strategy. The After Eighty randomised controlled trial
Age Ageing, 47 (1), 42-47
DOI 10.1093/ageing/afx121
Publications 2017
Morbidity outcomes after surgical aortic valve replacement
Open Heart, 4 (1), UNSP e000588
DOI 10.1136/openhrt-2017-000588
Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction
Heart, 103 (19), 1521-1527
DOI 10.1136/heartjnl-2016-310875
High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis
Clin. Chem., 63 (2), 552-562
DOI 10.1373/clinchem.2016.261107
High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis
Acta Bioquim. Clin. Latinoam., 51 (3), 395-407
Long-term effects of high-intensity interval training in heart transplant recipients: A 5-year follow-up study of a randomized controlled trial
Clin. Transplant., 31 (1), e12868
DOI 10.1111/ctr.12868
Publications 2016
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
N. Engl. J. Med., 375 (13), 1242-1252
DOI 10.1056/NEJMoa1607991
Mapping of near death experiences
Tidsskr. Nor. Laegeforen., 136 (23-24), 1968-1969
DOI 10.4045/tidsskr.16.0953
Intraoperative improvement in left ventricular peak systolic velocity predicts better short-term outcome after transcatheter aortic valve implantation
Interact Cardiovasc. Thorac. Surg., 22 (1), 5-12
DOI 10.1093/icvts/ivv277
Long-term outcomes after transcatheter aortic valve implantation: the impact of intraoperative tissue Doppler echocardiography
Interact Cardiovasc. Thorac. Surg., 23 (3), 403-409
DOI 10.1093/icvts/ivw159
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-STelevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial(+)
Eur. Heart J., 37 (30), 2406-2413
DOI 10.1093/eurheartj/ehw171
Invasive strategy in acute coronary syndrome reply
Lancet, 387 (10037), 2504
DOI 10.1016/S0140-6736(16)30673-0
Over 80 years and heart attack
Tidsskr. Nor. Laegeforen., 136 (16), 1324-1325
DOI 10.4045/tidsskr.16.0685
Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial
Lancet, 387 (10023), 1057-1065
DOI 10.1016/S0140-6736(15)01166-6
Publications 2015
Transcatheter Aortic Valve Implantation and Intraoperative Left Ventricular Function: A Myocardial Tissue Doppler Imaging Study
J. Cardiothorac. Vasc. Anesth., 29 (1), 115-120
DOI 10.1053/j.jvca.2014.10.016
Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain
Int. J. Cardiovasc. Imaging, 31 (5), 967-973
DOI 10.1007/s10554-015-0646-6
Publications 2014
Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13
Atherosclerosis, 234 (2), 352-359
DOI 10.1016/j.atherosclerosis.2014.03.021
Publications 2013
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: Prediction of significant coronary lesions and long-term prognosis
Am. Heart J., 165 (5), 716-724
DOI 10.1016/j.ahj.2013.02.008
Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarction
Int. J. Cardiol., 168 (1), 212-218
DOI 10.1016/j.ijcard.2012.09.092
Layer-Specific Quantification of Myocardial Deformation by Strain Echocardiography May Reveal Significant CAD in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
JACC-Cardiovasc. Imag., 6 (5), 535-544
DOI 10.1016/j.jcmg.2013.01.009
Publications 2012
The Terminal Part of the QT Interval (T peak to T end): A Predictor of Mortality after Acute Myocardial Infarction
Ann. Noninvasive Electrocardiol., 17 (2), 85-94
DOI 10.1111/j.1542-474X.2012.00493.x
Sequential ADP-stimulated light transmission and multiple electrode aggregometry in patients taking aspirin and clopidogrel after non ST-elevation myocardial infarction
Scand. J. Clin. Lab. Invest., 72 (4), 318-325
DOI 10.3109/00365513.2012.666565
Publications 2011
Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy-Results of a Randomized, Multicenter Trial
Transplantation, 92 (2), 235-243
DOI 10.1097/TP.0b013e31822057f1
Publications 2010
Turnuslegeboka 2010
Legeforl., Oslo (Ny rev. utg.), 458 s.
BIBSYS 102213836, ISBN 978-82-92934-05-0
Publications 2008
Prearrest administration of low-molecular-weight heparin in porcine cardiac arrest: Hemodynamic effects and resuscitability
Crit. Care Med., 36 (3), 881-886
DOI 10.1097/CCM.0B013E318164E781
Publications 2007
Turnuslegeboka
Legeforlaget, Oslo (4. utg.), 417 s.
BIBSYS 071016708, ISBN 978-82-993568-7-9
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis - Possible role in inflammation and plaque destabilization
Circulation, 115 (8), 972-980
DOI 10.1161/CIRCULATIONAHA.106.665893
Publications 2005
Journal 1: om å skrive enda bedre medisinske journaler
Unipub, [Oslo], 71 s.
BIBSYS 052096033, ISBN 82-997039-0-5
Publications 2004
Long-term prognosis after out-of-hospital cardiac arrest and primary percutaneous coronary intervention
Resuscitation, 63 (1), 49-53
DOI 10.1016/j.resuscitation.2004.04.006
Publications 2003
Acute hypoxia and activation of coagulation
Lancet, 362 (9388), 997-998
DOI 10.1016/S0140-6736(03)14378-4
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
Blood, 101 (11), 4387-4392
DOI 10.1182/blood-2002-10-3188
Publications 2002
Air travel and risk of venous thromboembolism
Thromb. Res., 108 (1), 15-17
DOI 10.1016/S0049-3848(02)00389-4
Reduced baroreceptor reflex sensitivity and increased blood pressure variability at 2400 m simulated cabin altitude
Aviat. Space Environ. Med., 73 (7), 632-634
Publications 2001
Studies of tissue factor pathway inhibitor, heparin and hypobaric hypoxia
Haematological Research Laboratory, Ullevål University Hospital, Oslo, 1 b. (flere pag.)
BIBSYS 011971886, ISBN 82-497-0041-4
Hypobaric hypoxia - Reply
Lancet, 357 (9260), 955-956
DOI 10.1016/S0140-6736(05)71652-4
Deep-vein thrombosis in long-haul flights
Lancet, 358 (9284), 837-838
DOI 10.1016/S0140-6736(01)05978-5
Low molecular weight heparin prevents activation of coagulation in a hypobaric environment
Blood Coagul. Fibrinolysis, 12 (5), 371-374
DOI 10.1097/00001721-200107000-00006
Left ventricular function and infarct size 20 months after primary angioplasty for acute myocardial infarction
Scand. Cardiovasc. J., 35 (6), 379-384
DOI 10.1080/14017430152754862
Reduced autonomic activity during stepwise exposure to high altitude
Acta Physiol. Scand., 173 (4), 409-417
DOI 10.1046/j.1365-201X.2001.00925.x
Publications 2000
A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1
Thromb. Res., 97 (6), 463-472
DOI 10.1016/S0049-3848(99)00183-8
Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins
Blood Coagul. Fibrinolysis, 11 (4), 343-348
DOI 10.1097/00001721-200006000-00005
Reperfusion therapy and strategies in acute myocardial infarction
Scand. Cardiovasc. J., 34 (4), 355-356
Association between acute hypobaric hypoxia and activation of coagulation in human beings
Lancet, 356 (9242), 1657-1658
DOI 10.1016/S0140-6736(00)03165-2
Physiological function of tissue factor pathway inhibitor and interaction with heparins
Haemostasis, 30 2, 48-56
Publications 1999
Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins
Br. J. Haematol., 107 (4), 756-762
DOI 10.1046/j.1365-2141.1999.01791.x
Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals
Br. J. Haematol., 105 (3), 641-647
DOI 10.1046/j.1365-2141.1999.01398.x
Publications 1998
Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action
Br. J. Haematol., 101 (4), 638-646
DOI 10.1046/j.1365-2141.1998.00770.x
Publications 1997
Tissue factor pathway inhibitor: Clinical deficiency states
Thromb. Haemost., 78 (1), 467-470